NVISION Laser Eye Centers, Inc.

ALISO VIEJO, Calif.--( BUSINESS WIRE )--NVISION Eye Centers, a renowned national leader in comprehensive eye care services, proudly announces the remarkable expansion of its subsidiary, NVISION Clinical Research, LLC. Spearheaded by the visionary leadership of its President and GM, Michael Gibertini, PhD, who assumed the role in August 2023, NVISION Clinical Research has swiftly expanded both its range of trials as well as the number of key investigators to lead this innovation. NVISION Clinical Research, LLC, an integral member of the NVISION family, is exclusively dedicated to facilitating clinical trial opportunities to patients treated by NVISION ophthalmologists. With more than 40 physician investigators across 20 clinical trial sites, NVISION Clinical Research, LLC operates one of the largest ophthalmology-specialized clinical trial site networks nationwide. The company remains committed to adding new investigators from NVISION’S expanding platform of more than 100 practice partners throughout the USA. “We are delighted to welcome Dr. Gibertini to our team of dedicated professionals who embody our Patient First ethos," expressed Chris Karkenny, CEO of NVISION. “In just a few short months, Dr. Gibertini has orchestrated the creation and implementation of an integrated, scalable platform for clinical research within NVISION, fostering new opportunities for professional growth for our physician partners, enhancing patient access and rapid study-startup for our trial partners, and reinforcing our unwavering commitment to clinical care excellence for our patients,” said Chris Karkenny, CEO of NVISION. Dr. Gibertini brings a wealth of experience to his role, having previously served as Chief Development Officer at Elligo Health Research and President of Clinical Development at Syneos Health. With over 30 years of expertise in pharmaceutical drug and device development, he is a recognized authority in clinical trial methodology and operations. As a seasoned executive in the clinical research arena, Dr. Gibertini is ideally positioned to steer NVISION Clinical Research, LLC through its next phase of growth. "I am thrilled by the rapid progress we have made in implementing our new ophthalmology research support model within the first few months," remarked Dr. Gibertini. "We have successfully enlisted new clinical investigators across Oregon, Utah, Arizona, Texas, and expanded our presence within California. Our mission is clear: to provide unwavering support to each and every NVISION ophthalmology practice in their pursuit of clinical trials." About NVISION Eye Centers NVISION Eye Centers is comprised of over 100 locations and ambulatory surgery centers strategically positioned as partnerships and joint ventures in California, Arizona, Nevada, Oregon, Utah and Texas. NVISION’s resolute commitment to quality, exemplified by its accomplished surgeons and dedicated staff, places Patients First, resulting in consistently outstanding outcomes. NVISION is uniquely positioned for continued growth and success in the changing landscape of vision care. For more information, please visit www.nvisioncenters.com .

ALISO VIEJO, Calif., May 5, 2023 /PRNewswire/ -- NVISION Eye Centers, a national leader in eye care services, has partnered with the Eye Institute of Corpus Christi, TX. This partnership marks NVISION's entry into the Corpus Christi market and strengthens its presence in Texas. The Eye Institute of Corpus Christi has been providing exceptional eye care services for over 25 years and specializes in glaucoma evaluation and treatment, laser and surgical treatment, and cataract evaluation and treatment. Ravi Krishnan, MD, is a board-certified ophthalmologist specializing in the diagnosis and treatment of glaucoma, cataracts, and ocular diseases. Dr Krishnan explained, "We are excited to join NVISION and to be able to offer our patients access to the latest technology and advancements in eye care." Dr. Krishnan continued, "NVISION's commitment to excellence in patient care and clinical outcomes is aligned with our practice philosophy, and we look forward to continuing to provide exceptional eye care services to the Corpus Christi community." "We are thrilled to welcome the Eye Institute of Corpus Christi to the NVISION family," said Chris Karkenny, CEO of NVISION Eye Centers. "Dr. Krishnan and Dr. Kevin Voigt, O.D., are exceptional eye care providers committed to delivering the highest level of care to their patients. Their expertise and dedication to their craft align with NVISION's core values and mission to provide the best possible eye care to our patients." Through this partnership with Eye Institute of Corpus Christi, both current and new patients will have access to NVISION's full suite of services, including LASIK, cataract surgery, corneal transplant surgery, oculoplastics, and other vision correction procedures. For more information, please visit NVISION's website at . Contact: NVISION Eye Centers [email protected] SOURCE NVISION

The transaction follows EWEI’s acquisition of several leading Southern California ophthalmology practices. Intrepid announced today that it served as the exclusive financial advisor to East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, on its majority sale to NVISION Eye Centers, one of the largest providers of comprehensive eyecare, LASIK, and cataract surgery services in the United States. EWEI’s seven clinics, two state-of-the-art surgery centers, aesthetic center, and clinical research division are strategically located across Los Angeles, with more than 35 practice partners, associates or affiliated community physicians providing more than 70,000 clinic visits per year. Since its founder Dr. George Kambara began serving the Japanese American community in 1947, this organization has been deeply connected to its local communities. Under the stewardship of its CEO, Dr. Fred Kurata, since 1984, EWEI has diversified into one of the region’s largest and most comprehensive eye care providers. Its managed services organization, Premiere Practice Management, led by its CFO, Naomi Nakagama, has completed 17 acquisitions or practice mergers. NVISION is a leading ophthalmology partner comprised of highly experienced providers of ophthalmic physician services. Based in Aliso Viejo, Calif., NVISION is an innovative leader in ophthalmology with a patient-first commitment in delivered care using the latest technology and treatment by some of the most talented and experienced surgeons in the industry. This transaction allows NVISION, with a combined 70 practice and ASC locations across five states, including California, Nevada, Oregon, Washington, and Arizona, to broaden its existing operations within the attractive Los Angeles market. Dr. Alex Liu will be promoted to the role of CEO of the EWEI-subsidiary to facilitate EWEI’s integration and to continue driving NVISION’s growth in the Los Angeles market. Dr. Kurata commented, “We are thrilled to become part of the NVISION family. This combination is highly complementary given our combined focus on outstanding patient care, geographic footprint and service offerings which will enable NVISION and EWEI to better serve the community.” He added, “Amid a challenging COVID environment, Intrepid’s Healthcare Group orchestrated a well-run process to help us secure an ideal strategic partner that will help EWEI grow for years to come.” Dr. Liu commented, “Intrepid was an invaluable resource to guide us through this complex transaction process with their expert financial analysis and strategic guidance, advising us at every stage. We felt they were an extension of our team.” “The EWEI clinical and operational leadership team did an outstanding job establishing EWEI as one of the largest and most respected practices in Southern California,” said Adam Abramowitz, Managing Director and Co-Head of Healthcare at Intrepid. “The EWEI team demonstrated a proven model to acquire, onboard, and integrate ophthalmology practices across Southern California. I’m excited to track their growth, which will accelerate with NVISION’s leadership and support.” “We were honored to help EWEI navigate its recent series of acquisitions and eventual transaction with NVISION,” commented Jonathan Bluth, Director and Co-Head of Healthcare at Intrepid. “This combination creates a larger EWEI with greater acquisition resources that can further expand its geographic footprint, ophthalmology sub-specialties, and research trials capabilities, improving access to leading eyecare services across Southern California.